Search all trials

Find therapies in clinical trials near you – page 19

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Gastrooesophageal cancer

Not recruiting

Registered drugNo placebo

Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Endometrial cancer recurrent+4

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Brimonidine Tartrate

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Guselkumab

Contact Research Centre

Idiopathic inflammatory myopathy

Not recruiting

Investigational

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Non-small cell lung cancer stage III+2

Not recruiting

Registered drugNo placebo

Study on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drugNo placebo

Study of luspatercept in patients with low-risk myelodysplastic syndrome (MDS) who do not require blood transfusions and have not received erythropoiesis treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Breast cancer+7

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Neuroendocrine tumour

Not recruiting

Registered drugNo placebo

Study of Cabozantinib in Adults with Advanced Low-Grade Neuroendocrine Tumors

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cabozantinib

Contact Research Centre

Fallopian tube cancer+2

Not recruiting

Registered drugNo placebo

Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Nemvaleukin Alfa

Contact Research Centre

Find therapies in clinical trials near you – page 19

352 trials match your criteria

Gastrooesophageal cancer

Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

Endometrial cancer recurrent+4

Study on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer

Malignant melanoma

Study of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery

Crohn's disease

Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease

Idiopathic inflammatory myopathy

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Non-small cell lung cancer stage III+2

Study on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy

Myelodysplastic syndrome

Study of luspatercept in patients with low-risk myelodysplastic syndrome (MDS) who do not require blood transfusions and have not received erythropoiesis treatment

Breast cancer+7

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Squamous cell carcinoma of head and neck

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Squamous cell carcinoma of head and neck

Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Neuroendocrine tumour

Study of Cabozantinib in Adults with Advanced Low-Grade Neuroendocrine Tumors

Fallopian tube cancer+2

Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.